Eligible participants must be healthy adults without any underlying conditions, aged between 18-59, with no history of contracting SARS, MERS or Covid-19, and who have not received any other Covid-19 vaccine.

The ARCT-154 vaccine will be administered to 100 volunteers at the Hanoi Medical University in Phase I.

Phase I of the clinical trials is scheduled to begin on August 15, when the ARCT-154 vaccine will be administered to 100 volunteers at the Hanoi Medical University.

Phase II will be conducted on 300 volunteers and Phase III will involve 20,600 volunteers.

In addition to the Hanoi Medical University, the Pasteur Institute in Ho Chi Minh City and the Vietnam Military Medical University will also take part in the clinical trials.

ARCT-154 is a Covid-19 vaccine developed by Arcturus Therapeutics using self-amplifying RNA technology, which has been improved to be effective against the Delta variant.

VinBioCare is planning to build a plant to manufacture this vaccine at the Hoa Lac High-Tech Park on the outskirts of Hanoi.

Urgent meeting held to evaluate homegrown Covid-19 vaccine Nano Covax

The National Ethics Committee in Biomedical Research under the Ministry of Health on August 7 held an urgent online meeting to review the results of the first phase of clinical trials of Vietnam’s domestically developed Covid-19 vaccine, Nano Covax, and to pass the mid-term assessment of its second phase.

Nearly 600,000 AstraZeneca vaccine doses arrive in HCMC

592,100 AstraZeneca Covid-19 vaccine doses arrived in HCMC's Tan Son Nhat International Airport Friday morning per VNVC contract.

Vietnam’s health ministry issues guidelines on mixing two vaccines

The Ministry of Health (MOH) has advised giving the same Covid-19 vaccine for the second dose as was used for the first one, as recommended by the World Health Organisation.

Vietnam to receive 50 mln Pfizer vaccine doses in fourth quarter

Around 50 million Pfizer Covid-19 vaccine doses would arrive in Vietnam in the fourth quarter, the health minister says.

Vingroup receives mRNA COVID-19 vaccine production technology

Conglomerate Vingroup has signed an agreement with Arcturus Therapeutics medicines biotechnology company of the US on the transfer of Covid-19 vaccine production technology.

Source: NDO